Qin Liu, Ph.D., M.D.
|Title||Assistant Professor of Ophthalmology|
|Institution||Massachusetts Eye and Ear Infirmary|
|Address||Massachusetts Eye & Ear Infrm|
5th Flr 563C
243 Charles St
Boston MA 02114
(login for email)
Available: 07/05/17, Expires: 05/31/19
Inherited retinal degenerations (IRDs) are important causes of vision loss that affect people of all ages. These disorders cause vision loss via dysfunction and death of the photoreceptor and retinal pigment epithelial cells of the retina. Gene augmentation therapy has been shown to be beneficial for patients with specific genetic forms of IRDs to date, but IRDs are genetically heterogeneous, and gene therapy may not be possible for all of the different genetic forms of disease, such as those caused by mutations in large genes, or by dominant gain-of-function mutations. This project is to test the use of CRISPR/Cas9 – mediated genome editing to treat several genetic forms of retinal degeneration that are not amenable to standard gene augmentation therapy approaches. The role of the defined student will be to learn and apply skills in genetics, molecular and cellular biologic, and CRISPR/Cas9 genome editing for treating one of the dominant forms of IRD in patient-derived iPS cells and gene targeted mouse models.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.